NAS
MIRM icon

Nykredit A/S’s Mirum Pharmaceuticals MIRM Stock Holding History

Nykredit A/S’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$247K Buy
+2,106
New +$211K ﹤0.01% 950

Other funds holding MIRM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Nykredit A/S's MIRM Position: Q2 2026 in Review

Nykredit A/S opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 2,106 shares worth $247K. The stake represents ﹤0.01% of the portfolio and ranks #950 among its holdings.

226 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Nykredit A/S held 2,106 shares of Mirum Pharmaceuticals worth $247K as of Q2 2026.
  • Mirum Pharmaceuticals was a new Nykredit A/S position in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #950 holding.
  • 226 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.